Keyphrases
5-aminolevulinate
39%
5-Aminolevulinate Synthase
19%
5-Aminolevulinic Acid (5-ALA)
32%
Acute Attack
29%
Acute Intermittent Porphyria
30%
Adverse Effects
12%
Allyl
15%
Amino Acids
15%
Biochemical Diagnosis
12%
Biosynthetic Pathway
11%
Chick Embryo
59%
Coproporphyrin
9%
Dimethyl Sulfoxide
17%
During Pregnancy
12%
End-stage Renal Disease
12%
Erythrocytes
14%
Erythropoietic Protoporphyria
18%
Ferrochelatase
31%
Growth Rate
21%
Haem
19%
Heme
39%
Heme Biosynthesis Pathway
33%
Heme Synthesis
26%
Hepatic Porphyria
10%
Hereditary Coproporphyria
12%
Hydroxymethylbilane Synthase
13%
Incubation
9%
Inhibitory Effect
23%
Israeli
21%
Latent Phase
9%
Liver
10%
Liver Cells
59%
Lymphocytes
23%
Lymphoproliferative Disorders
18%
Membrane Activity
14%
Membrane-active Compounds
9%
Phenobarbitone
9%
Photodynamic Inactivation
12%
Porphobilinogen
21%
Porphobilinogen Deaminase
45%
Porphyria
59%
Porphyrin
100%
Porphyrin Metabolism
26%
Propranolol
54%
Protoporphyrin
23%
Rat Liver
24%
Synthetase
14%
Transformed Cells
12%
Uroporphyrin
15%
Uroporphyrinogen Decarboxylase
15%
Pharmacology, Toxicology and Pharmaceutical Science
1,4 Dihydro 2,4,6 Trimethyl 3,5 Pyridinedicarboxylic Acid Diethyl Ester
7%
2 Amino 2 Methylpropionic Acid
6%
5 Aminolevulinate Synthase
25%
Acute Intermittent Porphyria
20%
Adrenergic Receptor Blocking Agent
7%
Adverse Event
12%
Allyl
8%
Allylisopropylacetamide
12%
Amino Acid
15%
Aminolevulinic Acid
26%
Autoimmune Pancreatitis
7%
Beta Adrenergic Receptor Blocking Agent
21%
Carbon 14
10%
Cardiovascular Risk
6%
Chick
41%
Colchicine
6%
Coproporphyrin
5%
Creatinine
6%
Ethanol
6%
Fish Oil
6%
Heme
19%
Hepatic Porphyria
9%
Hyperlipidemia
6%
Lidocaine
7%
Liver Disease
6%
Lymphoproliferative Disease
12%
Metalloporphyrin
6%
Metastasis
6%
Ofloxacin
6%
Oxprenolol
8%
Paclitaxel
6%
Pharmacotherapy
7%
Phenobarbital
12%
Photosensitivity
6%
Pindolol
6%
Porphobilinogen
10%
Porphobilinogen Deaminase
12%
Porphyria
47%
Porphyrin
64%
Propranolol
54%
Quinidine
7%
Rasmussen Syndrome
6%
Simvastatin
6%
Synthetase
18%
Trastuzumab
6%
Triton X-100
6%
Uroporphyrinogen
6%
Medicine and Dentistry
Acute Intermittent Porphyria
20%
Aminolevulinic Acid
18%
Autoimmune Pancreatitis
7%
Awareness
6%
Beta Adrenergic Receptor Blocking Agent
9%
Bullous Skin Disease
6%
Chick Embryo
16%
Coproporphyrinogen
6%
Creatinine
6%
Cyclic AMP
6%
Diagnosis
10%
Diagnostic Error
6%
Diagnostic Test
6%
Dimethyl Sulfoxide
7%
Disease
7%
DNA Synthesis
6%
End Stage Renal Disease
6%
Erythrocyte
12%
Erythropoietic Protoporphyria
6%
Heme Arginate
6%
Hereditary Coproporphyria
6%
Liver Cell
14%
Liver Disease
6%
Liver Transplantation
6%
Lymphocyte
9%
Lymphoproliferative Disease
12%
Melanoma B16
6%
Melanoma Cell
6%
Null Allele
6%
Ofloxacin
6%
Oxidoreductase
6%
Paclitaxel
6%
Pervasive Developmental Disorder
6%
Photodynamic Therapy
6%
Photosensitivity
7%
Porphobilinogen
7%
Porphobilinogen Deaminase
9%
Porphyria
37%
Porphyrin
35%
Porphyrin Metabolism
6%
Porphyrins Biosynthesis
8%
Propranolol
12%
Protoporphyrin
11%
Rasmussen Syndrome
6%
Symptom
7%
Synthetase
13%
Trastuzumab
6%
Urinary System
26%
Uroporphyrin
11%
Uroporphyrinogen
12%
